What is ADMA stock price today?

Visit our real-time dashboard for the current ADMA stock price and live market data.

Is ADMA stock going up or down today?

ADMA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ADMA stock now?

The decision to buy ADMA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ADMA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ADMA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ADMA stock overvalued or undervalued?

ADMA currently trades at a P/E ratio of 21.90 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if ADMA is fairly priced.

What is ADMA's P/E ratio?

ADMA has a price-to-earnings (P/E) ratio of 21.90, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ADMA's market cap?

ADMA (ADMA Biologics Inc) has a market capitalization of $4.39 billion, making it a small-cap stock.

What is ADMA's price to book ratio?

Price-to-book ratio for ADMA is available on our dashboard along with other valuation metrics.

Does ADMA pay dividends?

ADMA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ADMA's dividend yield?

ADMA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ADMA stock a good long-term investment?

ADMA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ADMA's revenue growth rate?

Revenue growth data for ADMA is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ADMA are available on our dashboard with complete income statement analysis.

What are the risks of investing in ADMA?

Key risks for ADMA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ADMA compare to its competitors?

Compare ADMA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ADMA's performance and positioning.

What is ADMA's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ADMA with bull, base, and bear case scenarios.

What do analysts say about ADMA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ADMA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ADMA's next earnings report?

ADMA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ADMA - ADMA Biologics Inc

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About ADMA Biologics Inc

ADMA Biologics Inc (ADMA) common stock

Price Chart

Loading chart...

ADMA Key Statistics

Market Cap

$4.39B

P/E Ratio

21.90

How ADMA Compares to Peers

ADMA is the smallest among peers, which may offer higher growth potential

P/E Rank

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
ADMA(This stock)	$4.39B	21.9	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 13, 2026 at 5:13 AM EDT

Ready to invest in ADMA?

Commission-free trading available. Affiliate links.

ADMA Lician Score

10% confidence

6.0/10

Good

ADMA has a Lician Score of 6/10 (Good). Strengths: Growth.

value

5.0

growth

8.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ADMAacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ADMA Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

8.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ADMA

Dashboard

Enter a ticker to analyze